No Data
Did Novo-Nordisk A/S fall, leaving Eli Lilly and Co to dominate the weight loss medication market?
Novo-Nordisk A/S faced a "Waterloo," with new drug effects falling short of expectations, causing a dramatic drop in stock prices. The landscape of the weight loss drug market is quietly changing; will Eli Lilly and Co become a sole oligopoly?
Tesla Cybertruck Units Reportedly Found With Cell Dent Issues: EV Giant Starts Replacing Battery Packs
Options Market Statistics: Tesla's Rollercoaster Week Ends with Friday Sell-Off; Options Pop
Tesla Model Y Could Lose Bestselling Title In Europe To This Non-EV Car
Weekly Buzz: It was a rough week just before the Winter Solstice
Jury Finds Qualcomm Did Not Breach Nuvia's License Agreement With Arm
Silverbat : Luckily sold over 119.25
面如冠玉的惠特克 : I sold half of it for 119.38.
Rick Esco OP 面如冠玉的惠特克 : Safe Rewarding Move
IM TRADER : Sold half of the position at 118.5. Sold too early